Lipella Pharmaceuticals Inc. Common Stock (NYSE: LIPO) — Healthcare · Share Price, Chart & Market Data
About: Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.07 (+125.81%)
LIPOLipella Pharmaceuticals Inc. Common Stock
Loading watchlist status…
Trade LIPO now
Lipella Pharmaceuticals Inc. Common Stock share price
LIPO price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 5:38 pm GMT+0
LIPO price performance
40%
5D
-2.778%
1M
-59.064%
YTD
-97.343%
1Y
LIPO price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 5:38 pm GMT+0
LIPO details
LIPO Market Signals